Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage

Hepatology

Volumn 29, Issue 1, 1999, Pages 27-32

  García Villarreal, Luis ^a   Martínez Lagares, Francisco ^a   Sierra, Angel ^a   Guevara, Clemencia ^a   Marrero, José M ^a   Jiménez, Elena ^a   Monescillo, Alberto ^a   Hernández Cabrero, Teresa ^a   Alonso, Jose M ^a   Fuentes, Rafael ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROBABILITY; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMIC PROCESSES; HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECURRENCE; SCLEROTHERAPY; SURVIVAL ANALYSIS;

EID: 0032897952     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290125     Document Type: Article

References (19)

1. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-809.
2. Ready JB, Rector WG. Morbidity and mortality of portal hypertension. Drugs 1989;37:1324.
3. Pagliaro L, Burroughs AK, Soerensen TIA, Lebrec D, Morabito A, D'Amico G, Tine E Therapeutic controversies and randomized controlled trials (RCTs): prevention of bleeding and rebleeding in cirrhosis. Gastroenterol Int 1989;2:71-84.
4. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. HEPATOLOGY 1995;22:332-354.
5. Richter GM, Noeldge G, Palmaz JC. The transjugular intrahepatic portosystemic stent-shunt: results of a pilot study. Cardiovasc Intervent Radiol 1990;13:200-207.
6. La Berge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, et al. Creation of transjugular intrahepatic portosystemic shunt with the wallstent endoprosthesis: results in 100 patients. Radiology 1993;187:413-420.
7. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP III, Shiffman ML, DemeoJ, Cole PE, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112:889-898.
8. Cabrera J, Maynar M, Granados R, Górriz E, Reyes R, Pulido Duque JM, Rodriguez San Roman JL, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996;110:832-839.
9. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP III, Shiffman ML, Cole PE, Tisnado J, et al. Transjugular intrahepatic portosystemic shunt (TIPS) compared with endoscopie sclerotherapy for the prevention of recurrent variceal hemorrhage: a randomized controlled trial. Ann Intern Med 1997;126:849-857.
10. Cello JP, Ring EJ, Olcott EW, Koch J, Gordon R, Sandhu J, Ostroff JW, et al. Endoscopie sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized controlled trial. Ann Intern Med 1997;126:858-865.
11. Rössle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, Hauenstein K-H, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997;349:1043-1049.
12. Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon JF, MacGilchrist AJ, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. HEPATOLOGY 1997;26: 1115-1122.
13. Sauer P, Theilmann L, Stremmel W, Benz C, Richter G, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997;113:1623-1631.
14. Merli M, Salerno F, Riggio O, de Franchis R, Fiacadori F, Meddi P, Primignani M, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. HEPATOLOGY 1998;27:40-45.
15. Sauer P, Theilmann L, Benz C, Richter G, Stremmel W, Stiehl A. Transjugular intrahepatic portosystemic stent shunt (TIPS) vs endoscopie banding in the prevention of variceal rebleeding: interim analysis of a randomized study [Abstract]. Gastroenterology 1997;112:A1374.
16. Parsons-Smith BG, Summerskill WHJ, Dawson AM, Sherlock S. The electroencephalography in liver disease. Lancet 1957;2:867-871.
17. de Franchis R, Pascal J, Ancona E, Burroughs AK, Henderson M, Fleig W, Groszmann R, et al. Definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 1992;15:256-261.
18. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastro-oesophageal varices and variceal bleeding. HEPATOLOGY 1985;5:419-424.
19. Burroughs AK, Mezzanotte G, Phillips A, McCormick A, McIntyre N. Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates. HEPATOLOGY 1989;9:801807.